Aleksandra Butrym

Walbrzych, DS, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Delayed Neurologic and Enterocolitis Reporting Patterns for Ciltacabtagene Autoleucel Versus Idecabtagene Vicleucel in EudraVigilance.

Delayed Neurologic and Enterocolitis Reporting Patterns for Ciltacabtagene Autoleucel Versus Idecabtagene Vicleucel in EudraVigilance.

Journal: Transplantation and cellular therapy

Published: July 23, 2026

From CAR-T to CAAR-T: redefining targeting strategies in B-cell malignancies through idiotype-directed cellular therapy.

From CAR-T to CAAR-T: redefining targeting strategies in B-cell malignancies through idiotype-directed cellular therapy.

Journal: Frontiers in immunology

Published: March 29, 2026

Self-perceived health literacy and its associations with health behaviours and self-rated health: a cross-sectional analysis of 120,000 Polish adults.

Self-perceived health literacy and its associations with health behaviours and self-rated health: a cross-sectional analysis of 120,000 Polish adults.

Journal: BMC public health

Published: January 27, 2026

Pre-transplant JAK-inhibition improves post-transplant outcome in myelofibrosis.

Pre-transplant JAK-inhibition improves post-transplant outcome in myelofibrosis.

Journal: Clinical and experimental medicine

Published: December 10, 2025

Trigger Points of Necroptosis (RIPK1, RIPK3, and MLKL)-Promising Horizon or Blind Alley in Therapy of Colorectal Cancer?

Trigger Points of Necroptosis (RIPK1, RIPK3, and MLKL)-Promising Horizon or Blind Alley in Therapy of Colorectal Cancer?

Journal: International journal of molecular sciences

Published: October 13, 2025

A Cluster of Risks: Correlates of Energy Drink Consumption with Smoking, Diet, and Burnout in the Polish Adult Population.

A Cluster of Risks: Correlates of Energy Drink Consumption with Smoking, Diet, and Burnout in the Polish Adult Population.

Journal: Nutrients

Published: October 11, 2025

Correction: Sokołowski et al. Immune Checkpoint Inhibitors (ICI) in Urological Cancers: A New Modern Era, but Not Generally Applied. Int. J. Mol. Sci. 2025, 26, 7194.

Correction: Sokołowski et al. Immune Checkpoint Inhibitors (ICI) in Urological Cancers: A New Modern Era, but Not Generally Applied. Int. J. Mol. Sci. 2025, 26, 7194.

Journal: International journal of molecular sciences

Published: September 02, 2025

Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL - real-life data analysis of the Polish Adult leukemia group.

Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL - real-life data analysis of the Polish Adult leukemia group.

Journal: Leukemia & lymphoma

Published: August 01, 2025

Post-transplant sorafenib effectively prevents relapse in FLT3-mutated acute myeloid leukemia.

Post-transplant sorafenib effectively prevents relapse in FLT3-mutated acute myeloid leukemia.

Journal: Expert review of hematology

Published: June 27, 2025

Immune Checkpoint Inhibitors (ICI) in Urological Cancers: A New Modern Era, but Not Generally Applied.

Immune Checkpoint Inhibitors (ICI) in Urological Cancers: A New Modern Era, but Not Generally Applied.

Journal: International journal of molecular sciences

Published: June 25, 2025

Checkpoint inhibitors in squamous cell carcinoma of the head and neck: History and new perspectives.

Checkpoint inhibitors in squamous cell carcinoma of the head and neck: History and new perspectives.

Journal: Dental and medical problems

Published: May 13, 2025

Second allogeneic transplantation in relapsed acute leukemia - a risk worth taking?

Second allogeneic transplantation in relapsed acute leukemia - a risk worth taking?

Journal: Annals of hematology

Published: May 08, 2025

Showing 1-12 of 87

Last Updated: 09/26/2026